Back to NVS Stock Lookup

NVS Related Analyst Ratings

May 20, 2013 11:43 AM UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Apr 8, 2013 07:33 AM BofA/Merrill Lynch Upgrades Novartis (NVS) to Neutral

Mar 15, 2013 11:26 AM JPMorgan Upgrades Novartis (NVS) to Overweight

Jan 23, 2013 06:44 AM Citi Upgrades Novartis (NVS) to Buy

Dec 12, 2012 07:14 AM Deutsche Bank Downgrades Novartis (NVS) to Hold, Doesn't See Outperformance

Dec 7, 2012 07:45 AM Morgan Stanley Downgrades Novartis (NVS) to Equalweight

Nov 21, 2012 08:37 AM Investors Willing to Wait on Novartis (NVS) Could Reap Dividends - Barron's

Sep 17, 2012 07:14 AM Exane BNP Paribas Upgrades Novartis (NVS) to Outperform

Sep 12, 2012 07:52 AM Jefferies on Pharmaceutical: Top Picks Still ABT and NVS

Aug 24, 2012 08:05 AM Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'

Aug 15, 2012 10:31 AM UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors

Jul 23, 2012 07:21 AM Jefferies Upgrades Onyx Pharmaceuticals (ONXX) to Buy; FDA Approves Kyprolis; Takeover Speculation Intensifies

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jul 5, 2012 10:47 AM Wells Fargo on Biogen (BIIB): Price Increases in MS Space Should Offer More Flexibility for BG-12

Jul 5, 2012 09:58 AM Elan Corp (ELN) Has Mutlipe Items Driving Action Today

May 10, 2012 09:13 AM SocGen Starts GSK, NVS, SNY at Buy, AZN at Hold

May 9, 2012 10:40 AM Auriga Maintains a 'Buy' on Perrigo Co. (PRGO); Accumulate Shares on Weakness

Apr 23, 2012 08:06 AM Jefferies Maintains a 'Buy' on Biogen (BIIB); Favorable Gilenya Update

Mar 6, 2012 07:53 AM JPMorgan Downgrades Novartis (NVS) to Neutral

Feb 6, 2012 06:49 AM BofA/Merrill Lynch Downgrades Novartis (NVS) to Underperform

Jan 9, 2012 09:33 AM Jefferies Raises Price Targets on Global Pharma Industry, Sets Top Picks of the Year

Nov 8, 2011 08:42 AM Collins Stewart Downgrades Novartis (NVS) to Hold

Oct 31, 2011 09:29 AM Cowen Downgrades Novartis (NVS) to Neutral

Oct 31, 2011 07:56 AM Cowen Downgrades Novartis (NVS) to Neutral

Oct 26, 2011 07:41 AM Exane BNP Paribas Downgrades Novartis (NVS) to Neutral

Oct 6, 2011 12:29 PM Shares of Anadys (ANDS) Trade Above $1; Analyst Believes Co. Could Get a Bid Following Setrobuvir Data

Sep 19, 2011 04:00 PM Leerink Swann Cuts Valuation on Momenta Pharmaceuticals (MNTA), Competition Increases

Sep 12, 2011 07:03 AM BofA/Merrill Lynch Downgrades Novartis (NVS) to Neutral

Aug 1, 2011 08:12 AM Needham & Company Maintains a 'Buy' on Regeneron Pharma (REGN); Upcoming August Event May Signal August Opportunities

Jul 20, 2011 09:16 AM Jefferies Cuts Price Target on Gen-Probe (GPRO) as Novartis (NVS) No Longer Looks to Buy

Jun 20, 2011 10:20 AM Eli Lilly (LLY) Might Be M&A Target if Things Don't Shape Up

Jun 10, 2011 07:28 AM Barclays Downgrades Novartis (NVS) to Underweight

Jun 9, 2011 08:19 AM Elan (ELN) Shares Surge as UBS Upgrades to Buy Amid Strong Tysabri Sales; Adds Stock to 'Key Calls List'

May 16, 2011 02:05 PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine

May 12, 2011 02:19 PM Barclays on Global Pharmaceuticals: Global Therapeutic Conference Preview: Multiple Sclerosis

Mar 7, 2011 02:16 PM Barclays on Healthcare Services: Weekly Flu Clues Review

Feb 9, 2011 11:14 AM Canaccord Genuity Morning Coffee on Teva Pharma (TEVA): Well, At Least It’s Not In Egypt.

Feb 2, 2011 01:20 PM Barclays Reiterates an 'Overweight' on Array BioPharma (ARRY); Reports FY2Q11, Data for MEK inhibitors in 2011

Dec 17, 2010 03:00 PM Barclays Maintains an 'Equalweight' on Elan Corp (ELN); Strong Gilenya Start May Translate to Tysabri Weakness

Dec 17, 2010 02:56 PM Barclays Maintains an 'Equalweight' on Biogen (BIIB); IMPACT RX Data Suggest Strong Gilenya Launch

Dec 7, 2010 08:21 AM Credit Suisse Upgrades NVS to Outperform, GSK to Neutral; Downgrades RHHBY to Neutral, AZN to Underperform

Nov 9, 2010 05:07 PM Leerink Swann Starts Novartis (NVS) at Outperform; Business Diversity & MS Survey Support Positive Outlook

Nov 3, 2010 07:54 AM Deutsche Bank Initiates Coverage on Elan Corp (ELN) with a Hold; Competitive Uncertainty and Pow Pipeline Confidence Keep Us on Sidelines

Nov 2, 2010 03:30 PM Canaccord Genuity Morning Coffee on Avanir Pharma (AVNR): Approved – Game On!

Oct 12, 2010 08:52 AM Morgan Joseph Reiterates a 'Buy' on ImmunoGen (IMGN); Deal Brings Unprecedented Financial Stability

Sep 22, 2010 07:00 AM Goldman Sachs Downgrades Novartis (NVS) to Neutral

Sep 15, 2010 02:38 PM Leerink Swann Raises Target on Savient (SVNT) to $22; Highlights Takeover Potential Following Krystexxa Approval

Jul 27, 2010 10:36 AM Citi Maintains a 'Buy' Rating on Alcon (ACL); First Look - Strong 2Q

Jul 26, 2010 01:02 PM Sanofi-Aventis (SNY) Cuts Outlook Amid Generic Lovenox Approval; Analysts Mixed

Back to NVS Stock Lookup